Recent technological advances in genomics, mass spectrometry, and epitope identification algorithms offer significant potential to identify novel antigenic targets for vaccine and immunotherapeutic development. On 30 April 2015, leading immunologists and bioinformatics scientists met to consider how best to utilize these advances towards deciphering the human antigenome and exploiting this information for prevention and control of infectious and neoplastic diseases.
No takes yet. Share an insight, caveat, or question.
Sette et al. (2015) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: